Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure.
暂无分享,去创建一个
D. Bodurka | M. Deavers | S. Frank | A. Jhingran | P. Eifel
[1] S. Frank,et al. Definitive radiation therapy for squamous cell carcinoma of the vagina. , 2005, International journal of radiation oncology, biology, physics.
[2] C. N. Coleman,et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.
[3] H. Menck,et al. The national cancer data base report on cancer of the vagina , 1998, Cancer.
[4] L. Delclos,et al. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. , 1996, International journal of radiation oncology, biology, physics.
[5] A. Herbst,et al. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. , 1990, Seminars in surgical oncology.
[6] A. Herbst,et al. An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. , 1988, Gynecologic oncology.
[7] L. Delclos,et al. Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis--the M. D. Anderson Hospital experience 1955-1982. , 1988, International journal of radiation oncology, biology, physics.
[8] A. Herbst,et al. Local therapy in stage I clear cell adenocarcinoma of the vagina , 1987, Cancer.
[9] A. Herbst,et al. Clear cell adenocarcinoma and the current status of DES‐exposed females , 1981, Cancer.
[10] A. Herbst,et al. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero , 1977, Cancer.
[11] A. Herbst,et al. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. , 1971, The New England journal of medicine.